Graypoint LLC decreased its holdings in shares of Danaher Co. (NYSE:DHR – Free Report) by 3.8% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 13,598 shares of the conglomerate’s stock after selling 533 shares during the period. Graypoint LLC’s holdings in Danaher were worth $3,121,000 as of its most recent SEC filing.
Other hedge funds have also recently made changes to their positions in the company. Fort Pitt Capital Group LLC raised its stake in shares of Danaher by 3.2% in the third quarter. Fort Pitt Capital Group LLC now owns 238,092 shares of the conglomerate’s stock worth $66,194,000 after purchasing an additional 7,421 shares during the last quarter. Good Life Advisors LLC purchased a new position in Danaher during the 3rd quarter worth $217,000. Harvest Portfolios Group Inc. grew its stake in shares of Danaher by 1.2% in the 3rd quarter. Harvest Portfolios Group Inc. now owns 202,263 shares of the conglomerate’s stock worth $56,233,000 after acquiring an additional 2,465 shares in the last quarter. Stifel Financial Corp raised its holdings in shares of Danaher by 1.3% in the third quarter. Stifel Financial Corp now owns 847,348 shares of the conglomerate’s stock valued at $235,583,000 after purchasing an additional 11,216 shares during the last quarter. Finally, Oddo BHF Asset Management Sas bought a new position in shares of Danaher during the third quarter valued at about $24,204,000. 79.05% of the stock is currently owned by institutional investors and hedge funds.
Analyst Upgrades and Downgrades
DHR has been the subject of several analyst reports. Wolfe Research upgraded shares of Danaher from a “peer perform” rating to an “outperform” rating and set a $285.00 price objective for the company in a research note on Thursday, October 31st. KeyCorp lifted their price target on Danaher from $290.00 to $310.00 and gave the stock an “overweight” rating in a report on Wednesday, October 23rd. Raymond James reduced their price objective on Danaher from $310.00 to $300.00 and set an “outperform” rating for the company in a research note on Wednesday, October 23rd. Royal Bank of Canada lowered their target price on Danaher from $333.00 to $311.00 and set an “outperform” rating on the stock in a research note on Wednesday, October 23rd. Finally, Barclays reduced their price target on shares of Danaher from $285.00 to $275.00 and set an “equal weight” rating for the company in a research report on Wednesday, October 23rd. Six investment analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company. Based on data from MarketBeat.com, Danaher currently has a consensus rating of “Moderate Buy” and an average target price of $286.80.
Danaher Price Performance
Danaher stock traded down $3.01 during midday trading on Friday, reaching $235.08. 2,863,201 shares of the stock were exchanged, compared to its average volume of 2,863,129. The company’s fifty day moving average is $235.93 and its 200-day moving average is $253.88. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.01 and a current ratio of 1.37. Danaher Co. has a 52 week low of $222.53 and a 52 week high of $281.70. The firm has a market cap of $169.79 billion, a PE ratio of 44.86, a PEG ratio of 4.33 and a beta of 0.83.
Danaher (NYSE:DHR – Get Free Report) last posted its quarterly earnings data on Tuesday, October 22nd. The conglomerate reported $1.71 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.57 by $0.14. The company had revenue of $5.80 billion during the quarter, compared to analyst estimates of $5.59 billion. Danaher had a return on equity of 10.62% and a net margin of 16.39%. The firm’s quarterly revenue was up 3.1% on a year-over-year basis. During the same quarter last year, the company earned $2.02 earnings per share. On average, sell-side analysts forecast that Danaher Co. will post 7.5 EPS for the current year.
Danaher Announces Dividend
The business also recently announced a quarterly dividend, which will be paid on Friday, January 31st. Investors of record on Friday, December 27th will be paid a $0.27 dividend. This represents a $1.08 dividend on an annualized basis and a yield of 0.46%. The ex-dividend date is Friday, December 27th. Danaher’s dividend payout ratio is currently 20.61%.
Danaher Profile
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.
Read More
- Five stocks we like better than Danaher
- Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours?
- Driving Forward: Lucid’s Growing Sales and Gravity SUV’s Impact
- ESG Stocks, What Investors Should Know
- Why Amazon’s Next Earnings Could Trigger a Stock Breakout
- What is a Dividend King?
- With This Kind of Data, The Fed Isn’t Cutting Rates This Year
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR – Free Report).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.